MTIC
GILD icon

Missouri Trust & Investment Company’s Gilead Sciences GILD Stock Holding History

Missouri Trust & Investment Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,319
Closed -$184K – 237
2026
Q1 		$184K Buy
1,319
+300
+29% +$42K 0.05% 147
2025
Q4 		$125K Hold
1,019
– – 0.04% 158
2025
Q3 		$113K Hold
1,019
– – 0.03% 164
2025
Q2 		$113K Hold
1,019
– – 0.04% 153
2025
Q1 		$114K Hold
1,019
– – 0.04% 151
2024
Q4 		$94.1K Buy
1,019
+19
+2% +$1.71K 0.03% 162
2024
Q3 		$83.8K Hold
1,000
– – 0.03% 173
2024
Q2 		$68.6K Hold
1,000
– – 0.03% 176
2024
Q1 		$73.3K Sell
1,000
-24
-2% -$1.85K 0.03% 178
2023
Q4 		$83K Sell
1,024
-400
-28% -$31.1K 0.03% 157
2023
Q3 		$107K Hold
1,424
– – 0.05% 140
2023
Q2 		$110K Buy
1,424
+824
+137% +$65.7K 0.06% 145
2023
Q1 		$49.8K Hold
600
– – 0.03% 165
2022
Q4 		$52K Hold
600
– – 0.03% 173
2022
Q3 		$37K Hold
600
– – 0.02% 190
2022
Q2 		$37K Hold
600
– – 0.02% 191
2022
Q1 		$36K Hold
600
– – 0.02% 208
2021
Q4 		$44K Buy
+600
New +$41.3K 0.03% 210

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Missouri Trust & Investment Company's GILD Position: Q2 2026 in Review

Missouri Trust & Investment Company sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,319 shares — an estimated $184K sold.

Missouri Trust & Investment Company first reported a position in GILD in Q4 2021 and held it in 18 quarters. The position peaked at $184K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Missouri Trust & Investment Company reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Missouri Trust & Investment Company sold 1,319 Gilead Sciences shares in Q2 2026, an estimated $184K.
  • Missouri Trust & Investment Company first reported a position in Gilead Sciences in Q4 2021 and held it in 18 quarters.
  • Missouri Trust & Investment Company's Gilead Sciences position peaked at $184K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.